📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Rigid, bivalent CTLA-4 binding to CD80 is required to disrupt the cis CD80/PD-L1 interaction. (2024)

First Author: Robinson MA

Attributed to: Applying advanced understanding of CTLA-4 function to optimise therapies for autoimmunity funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.celrep.2024.114768

PubMed Identifier: 39277860

Publication URI: http://europepmc.org/abstract/MED/39277860

Type: Journal Article/Review

Volume: 43

Parent Publication: Cell reports

Issue: 9

ISSN: 2211-1247